Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.257% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CC(C)c1cc(C(=O)N2CCCC(CCC(=O)N3CCN(c4ccccn4)CC3)C2)no1
b.) S=C(Nc1ccc(Cl)c(Cl)c1)N1CCN(c2ccccn2)CC1
c.) COc1ccc(OC)c(S(=O)(=O)N2CCCC(C(=O)NCc3ccncc3)C2)c1
d.) CN(C)c1nc(Nc2ccc(Cl)cc2)c(C#N)c(=O)o1
e.) CC(C)c1ccc(N2C(=O)CC(Sc3ncccn3)C2=O)cc1
Answer: e. CC(C)c1ccc(N2C(=O)CC(Sc3ncccn3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(N2C(=O)CC(Sc3ncccn3)C2=O)cc1
CC(C)c1ccc(N2C(=O)CC(Sc3ncccn3)C2=O)cc1
1-(4-propan-2-ylphenyl)-3-pyrimidin-2-ylsulfanylpyrrolidine-2,5-dione